SCHEMBL8975173

SCHEMBL8975173

CCC(=O)COc1ccc(CC2SC(=O)NC2=O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 11/20 0.71
MPC2 O95563 2/20 0.65
CYP2C8 P10632 2/20 0.65
CYP2C9 P11712 2/20 0.65
FFAR1 O14842 6/20 0.60
PPARA Q07869 2/20 0.60
CYP3A4 P08684 2/20 0.59
MAPT P10636 2/20 0.59
MEN1 O00255 1/20 0.59
ALDH1A1 P00352 1/20 0.59
TP53 P04637 1/20 0.59
CYP1A2 P05177 1/20 0.59
HPGD P15428 1/20 0.59
ALOX15 P16050 1/20 0.59
TSHR P16473 1/20 0.59
KMT2A Q03164 1/20 0.59
HSD17B10 Q99714 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
RXRA P19793 1/20 0.57
HRH3 Q9Y5N1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8282053 0.87 PPARG (0.70) PPARGMPC2CYP2C8CYP2C9FFAR1
Butane SCHEMBL14855731 0.86 PPARG (0.69) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL487116 0.85 PPARG (0.75) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL2608677 0.85 PPARG (0.67) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL19217579 0.85 PPARG (0.67) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL19828508 0.85 PPARG (0.67) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL1131336 0.85 PPARG (0.68) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL1130999 0.85 PPARG (0.67) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL1592234 0.84 PPARG (0.70) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL14188614 0.84 PPARG (0.67) PPARGMPC2CYP2C8CYP2C9FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5578620-A TREATMENT OF DIABETES AND HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1996-11-26 US disclosed
EP-0678511-A2 Thiazolidine and oxazolidine derivatives, their preparation and their medical use SANKYO COMPANY LIMITED (JP) 1995-10-25 EP disclosed